A Phase 2 Trial of Optimizing Platinum-Based Chemotherapy Based on ERCC1 Expression as First-Line Treatment in Patients With Locally Advanced or Metastatic Gastric Cancer

NCT01967875 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

27

Enrollment

OTHER

Sponsor class

Stopped slow enrollment

Conditions

Stomach Neoplasms

Interventions

DRUG: Capecitabine+Cisplatin
DRUG: Docetaxel+Capecitabine

Sponsor

China Medical University, China